BSE: 530617
SAMPRE NUTRITIONS LTD.
Manufactures confectionery and other packaged food/nutraceutical products from its base in Medchal, Telangana, supplying large consumer-goods companies on a contract-manufacturing basis. The business has separate manufacturing/supply deals in place with Tolaram Wellness, Rama Exports, and Reliance Consumer Products, each disclosed individually during 2025, and has longstanding ties to Mondelez, P&G, Dabur, Nestle and ITC through the parent Gurbani Group. The company is also setting up its first international footprint — a food processing and confectionery plant on a 30,000 square metre industrial parcel in Orascom Industrial Park, Egypt, via wholly-owned subsidiary Sampre Nutrition Holding Limited. For FY26, it reported revenue of Rs. 43.35 crore and a net profit of Rs. 3.08 crore, having returned to profitability after a loss in the prior year. The cost structure is split roughly evenly between raw materials (34.4% of revenue) and employee costs (30.8% of revenue), with other operating expenses at 23.8% and depreciation at 4.7%. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Contract manufacturing and supply of confectionery / packaged food products. Asset-light contract manufacturer of confectionery and packaged foods, with single-digit margins and a recent international expansion
Exhibit 1: Financial summary, FY24–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 25 | 25 | 43 |
| EBITDA (ex other income) | 4 | (4) | 5 |
| margin % | 16.4 | (15.4) | 11.0 |
| Owners' profit | 0 | (8) | 0 |
| EPS, as reported (₹) | 0.64 | (3.50) | 1.46 |
| ROE % · ROCE % | 1.0 · 7.4 | (8.4) · (5.4) | 2.9 · 2.6 |
| Debt / equity (x) | 0.78 | 0.19 | 0.17 |
| Cash from operations | 4 | 0 | (1) |
| Capex | (4) | (0) | (2) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | 7 | 6 | 8 | 11 | 10 | 7 | 15 |
| Profit before tax | 0 | 0 | (1) | (7) | 1 | 1 | 1 | (0) |
| Net profit | 0 | 0 | (1) | (7) | 1 | 1 | 1 | 1 |
| EPS (₹) | 0.11 | 0.18 | (0.30) | (3.50) | 0.34 | 0.82 | 0.06 | 0.64 |
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| NESTLE INDIA LIMITED | 2,25,418 | 59.2 | 43.71 | 41.0 | 67.9 | 54.7 | — | 24.4 |
| BRITANNIA INDUSTRIES LTD | 1,10,429 | 42.4 | 21.50 | 29.6 | 49.4 | 59.8 | 7.8 | 18.0 |
| ZYDUS WELLNESS LIMITED | 14,793 | 78.6 | 2.54 | 37.6 | 3.4 | 2.4 | 16.2 | 17.1 |
| BIKAJI FOODS INTERN LTD | 11,603 | 44.9 | 6.80 | 25.7 | 14.9 | 18.3 | — | 15.3 |
| BOMBAY BURMAH TRADING COR | 8,286 | 6.4 | 0.86 | 2.4 | 26.0 | 33.5 | 7.8 | 17.7 |
| MRS BECTORS FOOD SPE LTD | 5,577 | 18.9 | 4.39 | 19.6 | 11.1 | 13.1 | 18.3 | 14.7 |
| GOPAL SNACKS LIMITED | 3,057 | 36.4 | 6.38 | — | 15.4 | 19.4 | — | 7.6 |
| ADF FOODS LIMITED | 2,635 | 28.6 | 4.61 | 17.9 | 15.7 | 18.8 | 13.1 | 18.4 |
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 2.3 | 29.5 | 4 of 38 | 92% |
| P/B | 0.4 | 2.6 | 4 of 34 | 91% |
| ROCE | 1.5 | 7.4 | 31 of 40 | 23% |
| ROE | 2.9 | 7.7 | 26 of 34 | 24% |
| Debt / Equity | 0.2 | 0.1 | 21 of 33 | 38% |
| EBITDA margin | 5.5 | 9.9 | 23 of 33 | 31% |
| Revenue growth | 94.4 | 14.1 | 7 of 36 | 83% |
| Profit growth | 114.6 | 14.1 | 10 of 33 | 72% |
| Market cap | 40 | 96 | 28 of 43 | 36% |
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 15 Oct 2026 · SEBI Regulation 74(5) compliance certificate for Q2 FY27 | compliance | minimal | — | — |
| 27 Sept 2026 · Trading window closure ahead of Q2 FY27 results | compliance | minimal | — | — |
| 25 Sept 2026 · Allotment of 17.7 lakh shares to promoters on loan conversion | fund raising | high | — | — |
| 5 Sept 2026 · Sampre Nutritions 35th AGM: All 3 resolutions passed with overwhelming majority | board shareholder meetings | medium | — | — |
| 4 Sept 2026 · Sampre Nutritions 35th AGM held via video conferencing | board shareholder meetings | low | — | — |
| 29 Aug 2026 · BSE approval for promoter preferential share allotment to convert loans | fund raising | high | — | — |
| 14 Aug 2026 · Physical shareholders notified about 35th AGM and Annual Report access | compliance | minimal | — | — |
| 14 Aug 2026 · Corrigendum to 35th AGM notice - typographical error in scrutinizer date rectified | compliance | minimal | — | — |
| 12 Aug 2026 · AGM notice newspaper ad published for 35th AGM on Sept 4, 2026 | compliance | minimal | — | — |
| 10 Aug 2026 · FY26 annual report and 35th AGM notice filed | board shareholder meetings | medium | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.